Agency / Dark Spot Rx
FORMERLY DARK SPOT FORMULA
The updated product page describes hydroquinone and non-hydroquinone options, with a published pack size and a new price. Formula transitions should follow the clinician's plan, not an assumed subscription calendar.
Worth buying for a specific person with a specific problem. Read who.
ASSESSED ON 15% OF THE MODEL. 5 CRITERIA LEFT UNSCORED — SEE SCORING FOR WHY.
Treatment requires an individual prescription. Confirm the full cost and follow-up arrangements before paying.
Hydroquinone, kojic acid and niacinamide for dark spots. From $54.99 / month advertised.
VIEW Spot OnREAD OUR REVIEWThe verdict
The useful disclosure is that different formulas exist and may change during care. That is a reason to ask for the current prescription and transition plan, not to treat every ingredient on the page as one continuous combination.
The public offer is now $110 for an 18 g, nominal 60-day supply. This updated review removes the old price and a fixed cycling schedule that the current page does not establish for every patient.
- Separates hydroquinone and non-hydroquinone possibilities.
- States mass and nominal supply duration.
- No single course schedule applies to every reader.
- A higher hydroquinone strength claim does not establish a proportionally better result.
Every active, assessed
- Hydroquinone or non-hydroquinone combinationINDIVIDUAL PRESCRIPTION
Hyperpigmentation treatment
- BENCHMARK
- Diagnosis and formulation-specific evidence
- ASSESSMENT
- Potential ingredients include azelaic acid, kojic acid, green tea extract, resveratrol and hydrocortisone. Their listing is not a guarantee that each appears together.
| ACTIVE | CONC. | BENCHMARK | ASSESSMENT |
|---|---|---|---|
| Hydroquinone or non-hydroquinone combinationHyperpigmentation treatment | INDIVIDUAL PRESCRIPTION | Diagnosis and formulation-specific evidence | Potential ingredients include azelaic acid, kojic acid, green tea extract, resveratrol and hydrocortisone. Their listing is not a guarantee that each appears together. |
Scoring
- EVIDENCE FOR THE ACTIVEWEIGHT 30%NOT ASSESSED
Ingredient background is discussed separately. No performance score is assigned to an untested service or to a prescription that varies by patient.
- FORMULATION INTEGRITYWEIGHT 20%NOT ASSESSED
The exact dispensed preparation, manufacturer or patient-specific base was not inspected.
- DISCLOSUREWEIGHT 15%75/100
Publishes price, mass and the existence of different formulas; individual concentrations and transition dates still require the treatment plan.
- TOLERANCE IN USEWEIGHT 15%NOT ASSESSED
No patient panel or personal treatment course. Cannot infer tolerability from ingredient names or testimonials.
- TEXTURE & WEARWEIGHT 10%NOT ASSESSED
No product-in-hand testing.
- COST PER APPLICATIONWEIGHT 10%NOT ASSESSED
Published fees are compared in the text. Actual dispensed quantity, application amount and usable duration are needed for this criterion.
Open the review comparison tray →
The updated price and formula record
Agency lists Dark Spot Rx at $110 for 18 g, described as a 60-day supply. Its menu includes hydroquinone and non-hydroquinone preparations and several possible adjuncts. The FAQ describes provider-directed transitions to a non-hydroquinone formula; it does not establish one universal calendar. Confirm the ingredients and dates in your own plan.
A course has more detail than a renewal date
Write down the concern being treated, the planned application area, review date and what would lead to a change. If the proposed preparation contains a corticosteroid, ask about its role and duration. A subscription interface can organize delivery, but its next billing date does not independently determine how long a drug belongs in the treatment plan.
A defined approved combination with a specific melasma indication.
Another compound whose course needs explicit planning.
Questions about diagnosis, ingredients, duration and follow-up.
Do not make strength do the work of a trial
A concentration can be higher without demonstrating proportionally better clearing or acceptable tolerance for a particular person. Read product-page comparisons as claims to investigate. The relevant evidence must match the diagnosis and regimen, and evidence for a different finished product does not automatically validate this compound.
What belongs alongside the prescription
AAD's melasma guidance places diagnosis and sun protection within treatment. Ask your clinician how those fit your plan, including what to do if pigment worsens or irritation appears. A change in discoloration is a reason to reassess the situation; it should not automatically trigger buying a stronger formula.
Comparison limits
We did not receive a dispensed container or observe a treatment course. The updated score assesses the public specification only. Compare the full period of care, including transitions, before treating a lower price per shipment as a lower cost for the whole plan.
Who this is for
- Someone with a diagnosed pigment concern who can follow a clinician-directed course and review plan.
- You expect to continue a hydroquinone or steroid-containing formula indefinitely without reassessment.
- You are pregnant and considering hydroquinone; discuss an alternative with your clinician.
Treatment requires an individual prescription. Confirm the full cost and follow-up arrangements before paying.
Hydroquinone, kojic acid and niacinamide for dark spots. From $54.99 / month advertised.
VIEW Spot OnREAD OUR REVIEWThis is an editorial assessment of published information about aprescription product. It is not a diagnosis, not a prescription and not a substitute for your own prescriber. Hydroquinone and tretinoin are drugs. Decisions about them belong with a clinician who has seen your skin.
Sources
- S-01Agency — Dark Spot Rx Current $110 price, 18 g / 60-day supply, possible hydroquinone and non-hydroquinone formulas, and clinician-directed transitions. Checked 13 September 2026.
- S-02American Academy of Dermatology — melasma treatment Diagnosis, sun protection, hydroquinone, retinoid/corticosteroid combinations and alternative topical treatments. Checked 13 September 2026.
- S-03American Academy of Dermatology — pregnancy skin care Guidance to avoid retinoids and hydroquinone during pregnancy. Breastfeeding decisions need separate clinician advice. Checked 13 September 2026.
- S-04FDA — understanding compounded-drug risks Compounded preparations do not undergo FDA premarket review for safety, effectiveness or quality; they can meet individual medical needs. Checked 13 September 2026.